The value of full-length transcripts without bias

Legacy sequencing technologies have, undoubtedly, made comprehensive transcriptome analysis possible and is an invaluable tool for the study of human genetics and mechanisms of diseases. However, legacy technologies struggle to generate full-length transcripts, require fragmentation, and rely on converting RNA to cDNA. In this white paper, find out how nanopore sequencing overcomes these limitations to sequence full-length native RNA molecules to unlock more transcriptome biology.

In this white paper, you will:

• Learn the importance of transcriptomics and its recent developments
• Discover the limitations of legacy sequencing technologies
• Find out how nanopore sequencing overcomes these limitations
• Read real-world case studies of how researchers are utilising nanopore sequencing to deliver new insights